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The sickle erythrocyte (RBC) is a pathologic RBC that contains multiple membrane abnormalities. Some of these
abnormalities have been implicated in the pathophysiology of vasoocclusive crises characteristic of sickle cell disease;
others have yet to be defined in terms of their clinical significance. Recent information has shown that sickle RBC adhere
abnormally to cultured endothelial cells yet little is known about the ways in which sickle cells interact with model
membranes of defined size and lipid composition. We investigated this phenomenon by interacting sickle RBC with
artificial lipid vesicles (liposomes) containing acidic phospholipids. Our results demonstrate that sickle disease
(hemoglobin SS) RBC bind more of these liposomes than do normal or sickle trait (hemoglobin AS) RBC and that these
differences are accentuated by hypoxia-induced sickling. Binding of liposome phospholipid to sickled RBC was not
attributable to phospholipid exchange between liposomes and RBC and was consistent with a mechanism involving both
membrane fusion and a stable reversible adhesion of liposomes to the RBC membrane.
Investigations into the mechanism(s) underlying increased liposome binding to sickled RBC suggested that the known
reversible translocation of aminophospholipids, phosphatidylserine (PS) and phosphatidyl-ethanolamine (PE), from the
inner to the outer leaflet of the reversibly sickled RBC (RSC) plasma membrane during sickling may be a component of
increased liposome binding to RSC. This idea was supported from results […]
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A B S T R A C T The sickle erythrocyte (RBC) is a patho-
logic RBC that contains multiple membrane abnor-
malities. Some of these abnormalities have been im-
plicated in the pathophysiology of vasoocclusive crises
characteristic of sickle cell disease; others have yet to
be defined in terms of their clinical significance. Re-
cent information has shown that sickle RBC adhere
abnormally to cultured endothelial cells yet little is
known about the ways in which sickle cells interact
with model membranes of defined size and lipid com-
position. We investigated this phenomenon by inter-
acting sickle RBC with artificial lipid vesicles (lipo-
somes) containing acidic phospholipids. Our results
demonstrate that sickle disease (hemoglobin SS) RBC
bind more of these liposomes than do normal or sickle
trait (hemoglobin AS) RBCand that these differences
are accentuated by hypoxia-induced sickling. Binding
of liposome phospholipid to sickled RBCwas not at-
tributable to phospholipid exchange between lipo-
somes and RBCand was consistent with a mechanism
involving both membrane fusion and a stable revers-
ible adhesion of liposomes to the RBCmembrane.
Investigations into the mechanism(s) underlying in-
creased liposome binding to sickled RBC suggested
that the known reversible translocation of aminophos-
pholipids, phosphatidylserine (PS) and phosphatidyl-
ethanolamine (PE), from the inner to the outer leaflet
of the reversibly sickled RBC(RSC) plasma membrane
during sickling may be a component of increased li-
posome binding to RSC. This idea was supported from
results of experiments in which normal RBC were
treated with diamide resulting in the expression of
outer leaflet PE and PS and a stimulation of liposome
binding to these cells. However, sickle RBCseparated
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according to cell density on stractan gradients showed
that irreversibly sickled RBC (ISC) were less capable
of liposome binding than were discoid RSC. Since ISC
are known to contain elevated levels of outer leaflet
aminophospholipids, such a result suggests that other
changes in the plasma membrane of sickle cells, in
addition to phospholipid reorganization, are probably
involved in enhanced liposome binding to these cells.
In other experiments, we showed that liposomes con-
taining L-phenylalanine were capable of delivering
this antisickling agent into intact sickle RBCas dem-
onstrated by the partial inhibition of hypoxia-induced
sickling in vitro. Our results suggest that liposomes can
be used as sensitive probes for investigating changes
in RBC membrane properties, especially those that
affect intermembrane interactions, and that liposomal
transport systems may have significant implications in
the therapy of sickle cell disease.
INTRODUCTION
Although the primary lesion in the sickle erythrocyte
(RBC)' is the presence in these cells of sickle hemo-
globin (Hb), many other components within the sickle
RBC are also abnormal. Recent studies have shown
that there are marked changes in the sickle RBC
plasma membrane. For example, the phospholipid or-
ganization of the plasma membrane is altered in deox-
ygenated sickle RBC(1). Deoxygenation results in the
' Abbreviations used in this paper: BSKG, phosphate-buff-
ered saline containing 5 mMpotassium and 1 1.1 mMglucose;
DPPC, labeled, L-a-dipalmitoyl[methyl-'4C or 'H]choline;
Hb, hemoglobin, Hct, hematocrit; ISC, irreversibly sickled
RBC; PC, phosphatidylcholine; PE, phosphatidylethanol-
amine; PHE, L-phenylalanine; PLA2, phospholipase A2; PS,
phosphatidylserine; RBC, erythrocyte; RSC, reversibly sick-
led RBC; WBC, leukocytes.
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accelerated transbilayer movement of phospholipids
(2) leading to an increased exposure of the amino-
phospholipids phosphatidylserine (PS) and phospha-
tidylethanolamine (PE) on the external leaflet of the
plasma membrane (1). In addition, the sickle RBC
membrane has elevated levels of surface glycoproteins
(3), membrane-bound calcium (4, 5) and Hb (6), ab-
normalities in the structure of the spectrin-actin cy-
toskeleton (7), and an increased susceptibility to lipid
peroxidation (8). One possible result of such cumula-
tive changes in the sickle RBCplasma membrane could
be an altered interaction of sickle RBCwith other cells.
Indeed, Hoover et al. (9) and Hebbel et al. (10) have
shown independently that sickle RBCwere consider-
ably more adherent to cultured endothelial cells than
were normal RBC. Hebbel et al. (11) also demonstrated
a strong correlation between sickle RBCadherence and
clinical severity of disease. These workers found that
oxygenated sickle RBCwere more adherent than were
deoxygenated sickle RBC, although many of the bio-
chemical changes in the sickle RBC membrane are
known to be exaggerated by hypoxia. They suggested
that the RBC shape transformations accompanying
hypoxia may render the sickled RBC less capable of
adhesion in such an assay system. Here, we have in-
vestigated the interactions of liposomes with normal
and sickle RBC to understand how sickling-induced
changes in membrane surface properties affect inter-
membrane interactions. Liposomes, because of their
relatively small size (0.1 jim), might be expected to
interact to a greater extent with the sickled RBCthan
would cultured cells, thus permitting a more detailed
examination of the manifestations of changes in the
sickle RBC membrane. We found that liposomes in-
teracted to a much greater extent with the sickled RBC
than with the discoid sickle or normal RBC. In addi-
tion, we were able to partially inhibit sickling in vitro
by interacting sickle RBC with liposomes containing
L-phenylalanine (PHE), indicating that liposomal con-




PS was prepared from bovine brain and phosphatidylcho-
line (PC) from egg yolk as described previously (12, 13), or
purchased from Avanti Polar Lipids, Birmingham, AL. All
lipids showed single spots when subjected to thin-layer chro-
matography using two different solvent systems (14). Lipids
were stored under nitrogen in sealed ampules at -50°C.
L-a-Dipalmitoylphosphatidyl[methyl-'4C or 3H]choline
(DPPC), [9,10-3H(N)]triolein and [carboxyl-'4C]inulin were
obtained from New England Nuclear, Boston, MA. Diamide
(azodiacarboxylic acid bis[dimethylamide]) and PHE were
from Sigma Chemical Co., St. Louis, MO. Stractan II was
from St. Regis Paper Co., Tacoma, WA. AcquaMix aqueous
liquid scintillation cocktail was obtained from WestChem,
San Diego, CA. All other chemicals were reagent grade from
standard sources.
Procedures
Preparation of vesicles. Large unilamellar vesicles (LUV)
composed of PS/PC (3:1 molar ratio) were prepared by the
reverse-phase evaporation technique (15), with some modi-
fications (16). Radiolabeled DPPCor triolein were added in
trace amounts (0.21 and 0.007% of total lipid, respectively)
to the lipid mixture in chloroform. After the vesicles were
formed they were uniformly sized to 0.1 Am by extrusion
through polycarbonate filters (Uni-Pore, Bio-Rad Laborato-
ries, Richmond, CA) (17, 18). Vesicles containing encapsu-
lated material (['4Clinulin or PHE) were separated from non-
encapsulated material on a Sephadex G-75 (1.5 X 15 cm)
column (elution buffer: 20 mMsodium Hepes, pH 7.4 con-
taining 150 mMNaCI). All vesicle preparations were cen-
trifuged at 10,000 g for 30 min to separate multilamellar
vesicles from LUV. Vesicles prepared by this method were
stored under nitrogen at 4°C and were stable for at least 1
mo. The concentration of lipid in the various vesicle prep-
arations was determined by standard procedures (19).
Sample preparation. After obtaining informed consent,
fresh blood samples from patients with sickle cell disease (Hb
SS), sickle cell trait (Hb AS), or from healthy normal
controls (Hb AA) were collected in sodium heparin. Cells
were separated from plasma by centrifugation (at 700 g for
10 min at 4°C), leukocytes (WBC) were removed by aspi-
ration of the buffy coat and the resulting RBC suspension
was washed three times with 15 vol of phosphate-buffered
saline (PBS, 20 mMsodium-phosphate, pH 7.4, containing
150 mMNaCl). Washed RBCwere resuspended to 20% he-
matocrit (Hct) in PBS and cell counts (RBC and WBC)were
obtained using the Coulter model S electronic cell counter
(Coulter Electronics Inc., Hialeah, FL). WBCcontamination
generally represented <1,000 cells/Al RBCsuspension and
was similar for normal, sickle-trait and sickle-disease RBC
preparations. Deoxygenated RBC were prepared by incu-
bating the RBC in a stoppered flask continuously flushed
with humidified nitrogen for 1 h at 37°C. Oxygenated RBC
were incubated in room air. In some experiments, RBCwere
first induced to sickle by incubating them under nitrogen
as above and then reoxygenated in room air (15 min) until
they returned to a biconcave shape. Samples of RBCfollow-
ing oxygenation or deoxygenation were fixed in PBS con-
taining 2% (final concentration) glutaraldehyde (in which
oxygenated or deoxygenated conditions were maintained)
and examined using light microscopy.
Liposome-RBC incubations. Oxygenated or deoxygen-
ated RBC(4% final Hct) were incubated with liposomes (10-
1,000 AM liposome phospholipid) in a total volume of 0.2
ml buffer A (20 mMsodium-Hepes, pH 7.4, containing 150
mMNaCl) at 37°C with constant gentle rotation for 1 h, or
as indicated. Oxygenated conditions were maintained by
incubating under room air. Deoxygenated conditions were
maintained by performing the incubations in sealed tubes
(12 X 75 mm) constantly flushed with humidified nitrogen.
Buffers used for the deoxygenated experiments were equil-
ibrated with nitrogen in sealed flasks for at least 1 h before
their use. Liposome binding to RBC was measured by the
residual uptake of radiolabeled liposomes following exhaus-
tive washing of the RBC-liposome complex (three to four
times, cells collected at 1,500 g for 5 min at 4°C) with buffer
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A (0.5 ml) or buffer A containing 6 mMdisodium EDTA,
as indicated. Oxygenated RBC were washed with oxygen-
ated (room air) buffer and deoxygenated RBCwere washed
with deoxygenated (nitrogen-flushed) buffer. Washed RBC-
liposome complexes were dissolved in 0.2 ml of 1% sodium
dodecyl sulfate containing 50 mMi3-mercaptoethanol, fol-
lowed by boiling for 1-2 min, the resulting lysate was de-
colorized by addition of 7% (final concentration) H202 and
the mixture was allowed to stand overnight at room tem-
perature. The decolorized solution was transferred to scin-
tillation vials containing 10 ml aqueous scintillation
cocktail (AquaMix) for counting in a liquid scintillation spec-
trometer.
Cell separation. Blood (40 ml) from normal and sickle
cell patients was collected in heparinized tubes. RBCwere
separated from plasma by centrifugation (1,000 g for 10 min
at 4°C), WBCwere removed by aspiration of the buffy coat
and the resultant RBCsuspension was further washed (three
times) with PBS containing 5 mMpotassium and 11.1 mM
glucose (BSKG). Washed RBCwere resuspended to 20% Hct
and layered on top of discontinuous gradients of Stractan II,
prepared according to Corash et al. (20), as described by
Clark et al. (21). Gradients were centrifuged for 30 min at
4°C in the Beckman SW25.1 swinging bucket rotor (Beck-
man Instruments, Inc., Fullerton, CA) at 20,000 rpm in a
Beckman model L8-80 ultracentrifuge. Separated RBCfrac-
tions (top (20% stractan), middle (23% stractan), bottom (26%
stractan)) were collected and washed (three times) with
BSKG. Top and middle fractions of sickle blood contained
<2% irreversibly sickled cells (ISC) whereas bottom fractions
contained >70% ISC, as determined by light microscopy of
representative samples fixed in 2% (final concentration) glu-
taraldehyde. Top fractions of normal and sickle blood con-
tained <8% and >25% reticulocytes, respectively (as deter-
mined by methylene blue-stained smears). Middle and bot-
tom fractions of both normal and sickle blood contained
<2% reticulocytes.
Treatment of RBCwith diamide. Normal washed RBC
were treated with the sulfhydryl-specific oxidizing agent
diamide, as described by Haest et al. (22). RBCof 10% Hct
in isotonic phosphate buffer (10 mMsodium phosphate, pH
8.0, containing 90 mMpotassium chloride, 45 mMsodium
chloride, and 44 mMsucrose) were incubated with appro-
priate amounts of a stock solution of 100 mMdiamide to
give a final diamide concentration of 1-5 mM. Incubations
proceeded for 1 h at 37°C after which time the RBCwere
collected and washed (three times) with PBS. The diamide-
treated RBCwere allowed to stand for an additional 1 h at
37°C before use in the liposome-RBC interaction experi-
ments or phospholipase A2 (PLA2) treatment. Phospholipid
degradation using bee venom PLA2 was performed as de-
scribed previously (1).
RESULTS
Liposome binding to RBC. Liposome binding to
RBCcould best be described by a rectangular hyper-
bola with a tendency to saturate at higher lipid con-
centrations (Fig. 1). Since the number of liposomes
bound to normal RBC was found to be small (-95
liposomes/RBC at 100 ,uM liposome lipid) we have
used relatively high concentrations of liposome lipid
(100-1,000 ,M) in all subsequent experiments. Lipo-
some binding to RBC was linear with respect to the
length of incubation (between 0 and 60 min at 37°C)
(Fig. 2) and to RBCHct (between 2 and 10% Hct, data
not shown). The data plotted in Fig. 2 suggests that
liposome binding is characterized by a very rapid ini-
tial uptake of liposomes (0-10 min) followed by a
slower linear rate of uptake (>10 min). Such a result
is consistent with liposome uptake by "high"- and
"low"-affinity RBC-liposome binding sites.
When liposome binding was compared between nor-
mal and sickle RBC, we found that oxygenated sickle
RBCbound significantly more liposomes than did nor-
mal RBC (Fig. 3). When liposome binding was com-
pared between deoxygenated and oxygenated sickle
RBC, it was apparent that the hypoxic sickle RBCwere
binding several times more liposomes than were the
oxygenated sickle RBC(Fig. 3). Since both oxygenated
and deoxygenated sickle RBCpreparations were from
the same blood donor and thus contained identical
numbers of reticulocytes, it was apparent that the in-
creased binding of liposomes to sickled RBCwas due
to some property related specifically to the sickled
RBCand not to reticulocytosis per se. This was further
demonstrated using sickle-trait (Hb AS) RBC (Fig. 4).
The percentage of reticulocytes in sickle-trait blood
is similar to that in normal blood (24) and indeed
sickle-trait RBC do not normally sickle in vivo al-
though they can be induced to sickle in vitro by in-
cubating them under hypoxic conditions. Under such
conditions, sickle-trait RBCbound significantly more
liposomes than they did when oxygenated. However,
the extent of liposome binding to the deoxygenated
sickle-trait RBC was considerably less than that of
deoxygenated sickle-disease (Hb SS) RBC at compa-
rable liposome concentrations.
Exchangeability of liposome and RBC glyceroli-
pids. It is now well established that certain membrane
glycerolipids may exchange between membranes both
in the presence and absence of specific glycerolipid
exchange proteins. Indeed, phospholipid exchange
proteins have been used successfully to measure glyc-
erolipid distribution and translocation in several bio-
logical membranes including those of RBC (25, 26).
To determine whether we were actually measuring
true liposome binding to RBC or simply an artifact
due to enhanced glycerolipid exchange between li-
posomes and RBC, we compared the binding to normal
and sickle RBCof liposomes labeled with [3H]triolein,
a nonexchangeable glycerolipid (27) and liposomes la-
beled with ['4C]DPPC, an exchangeable glycerolipid
(28). We found that the extent of radiolabeled lipo-
some uptake by RBCwas similar using liposomes la-
beled with either marker (data not shown). Additional
support against lipid exchange was obtained from ex-
periments using liposomes with both a lipid marker
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FIGURE 1 Incorporation of liposomes (PS/PC, 3:1, 0.1 lsm) into RBC. Normal RBC (4% Hct)
were incubated with liposomes (10-1,000 AM) labeled with [3H]triolein (0.007% of liposome
lipid) at 370C in Hepes-buffered saline for 1 h. Liposome incorporation was determined by
measurement of residual RBCradioactivity following exhaustive washing of the liposome-RBC
complex with PBS. RBCnumber was obtained using the Coulter model S electronic cell counter.
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FIGURE 2 Incorporation of liposomnes into RBCas a function
of incubation time. Normal RBCwere incubated with lipo-
somes (200 uM) at 370C in Hepes-buffered saline for from
0 to 60 min. Liposome composition, incorporation into RBC,
and procedures for determining RBCnumber were described
in Fig. 1. Data points represent the mean±1 SD of three
determinations.
(['4C]DPPC) and an aqueous space marker (['4C]inulin).
RBC incubated with such double-labeled liposomes
incorporated both lipid and aqueous space labels
whereas RBCincubated with DPPC-labeled liposomes
plus free radiolabeled inulin incorporated only radio-
labeled DPPC(data not shown). Wetherefore feel that
the mechanism of increased liposome binding to sickle
RBCcannot be explained by an elevation in the rate
of glycerolipid exchange between liposomes and sickle
RBC, but to some property directly attributable to the
sickle RBC membrane that results in increased lipo-
some-RBC interactions.
Liposome binding to diamide-treated RBC. Al-
though our use of liposomes as a probe to examine
surface properties of the sickle RBCwas intended to
generate information regarding cumulative changes
in the sickle RBCmembrane as a consequence of the
sickling event, we were particularly interested in those
changes relating specifically to phospholipid reorga-
nization. The distribution of phospholipids within the
membrane of sickled RBC is different from that in





















































FIGURE 3 Incorporation of liposomes (100-400 ,uM) into
normal (A), oxygenated sickle (@), and deoxygenated sickle
(0) RBC. Oxygenated RBCwere preincubated at 37°C for
1 h under room air. Deoxygenated RBCwere preincubated
at 37°C for 1 h under humidified nitrogen. Liposonle com-
position, incubation conditions, measurement of liposome
incorporation and RBC number were described in Fig. 1.
Deoxygenated normal RBC were also tested and liposome
incorporation into these cells followed the same pattern as
that for oxygenated normal RBC. Data points represent the
mean±1 SD of at least three determinations.
nonsickled RBC. Compared with the nonsickled RBC,
the outer leaflet of the sickled (hypoxic RSCor ISC)
RBC is enriched in PE and contains PS while being
depleted in PC (1). Since membranes containing PE
and PS are fusogenic in model membrane systems (30),
we postulated that such phospholipid reorganization
during sickling could be at least partially responsible
for the observed increased binding of liposomes to sick-
led RBC. To test this hypothesis, we treated normal
RBC with the sulfhydryl-specific oxidizing agent
diamide (azodicarboxylic acid bis[dimethylamide]),
which induces a loss of cytoskeletal integrity and re-
sults ih the translocation of PE and PS from the inner
to the outer leaflet of the RBCplasma membrane (22).
As shown in Fig. 5, increasing the concentration of
diamide exposed to normal RBCresulted in an increase
in the amount of PE and PS on the outer leaflet of the
membrane (panel A) while simultaneously stimulating
the binding of liposomes to these RBC(panel B). Thus,
liposome binding to diamide-treated RBC correlated
well with the availability of PE and PS contained
within the outer leaflet of the plasma membrane.
Liposome binding to density-separated RBC. Since
sickle cell disease is characterized by reticulocytosis
I-
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Fi(;URE 4 Incorporation of liposomes (100-400 MM) into
oxygenated (@) or deoxygenated (0) sickle trait (Hb AS)
RBC. Oxygenated RBCwere preincubated at 37°C for 1 h
in room air. Deoxygenated RBCwere preincubated at 37°C
for 1 h under humidified nitrogen. Li4posome composition,
incorporation into RBC, and measurement of cell number
were described in Fig. 1. Data points represent the mean±+
SD of three determinations.
(23), we could not exclude the possibility that in-
creased liposome binding to sickle cells was due to
enhanced binding to sickle reticulocytes. Wetherefore
separated normal and sickle RBC into fractions ac-
cording to cell density on Stractan II. Wefound that
the top (least dense) fraction of sickle RBC, which was
reticulocyte-rich but essentially devoid of ISC, bound
the largest amount of liposomes (Table I). In contrast,
normal RBC from the bottom (mrost dense) fraction
bound the largest amount of liposomes. RBCfrom the
middle fractions of both normal and sibkle blood
bound similar amounts of liposomes. For both normal
and sickle cells, differences in RBC-liposome binding
between density separated fractions could not be ac-
counted for solely on the basis of differences in RBC
surface area. For normal RBC, the difference in sur-
face area of top vs. bottom fractions amounted to <1%
whereas for sickle RBC this difference was -4%.
Role of divalent cations in the binding of liposomes
to RBC. In model membrane systems, fusion or ag-
gregation of PS- or PE-containing vesicles is divalent
cation dependent (29, 30). We, therefore, investigated
what effect divalent cations might be exerting on li-
posome binding to RBC. To test the hypothesis that
the observed increased liposome binding to sickled
RBC was due, in part, to a leakage of intracellular
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FIGURE 5 Liposome incorporation into diamide-treated RBC. Normal RBC (10% Hct) were
incubated with diamide (1-5 mM) at 37°C for 1 h following which time the RBCwere washed
free of diamide. Treated RBCwere allowed to stand at 37°C for an additional 1 h before the
addition of liposomes (1 mM) or bee venom PLA2. Results are presented as the percentage of
total lipid extractable RBCPS, PE, and PC degraded by PLA2 (panel A), and liposorne incor-
poration into these cells (panel B) as a function of diamide concentration. Liposome composition,
incorporation into RBC, and measurement of cell number were-described in Fig. 1. Data points
presented in panel B represent the mean±1 SD of three determinations.
divalent cations during RBC sickling, we performed
the RBC-liposome incubations in the presence of the
divalent cation-chelating agent EDTA. As shown in
TABLE I
Liposome Binding to Subpopulations of RBC
Stractan fractiont RBCsample n Lipid incorporated
nmol/108 RBC
Top AA 6 1.9±0.1
SS 7 2.8±0.6
Middle AA 5 1.9±0.1
SS 7 2.0±0.5
Bottom AA 3 4.0±0.6
SS 7 2.0±0.2
Values are mean±1 SD; n, number of determinations.
RBCwere incubated with liposomes (200 ,M) for 1 h at 37°C.
I Top and middle fractions of sickle RBCcontain <2%ISC. Bottom
fraction of sickle RBCcontain >70% ISC.
Fig. 6, EDTA had no effect on liposome binding to
normal or sickle(d) RBC. Furthermore, when oxygen-
ated or deoxygenated RBCwere first incubated with
liposomes and then washed in EDTA-containing buffer,
the extent of liposome binding was not altered (data
not shown). Although such results suggest that lipo-
.some binding to sickled RBC is independent of the
leakage of any intracellular divalent cations, they do
not rule out the participation of membrane-associated
divalent cations in the mechanism of liposome binding.
It is possible that a pool of divalent cations are located
within the RBCsurface in such a way that they are
inaccessible to EDTA yet can still participate in li-
posome-RBC interactions.
Reversibility of liposome binding. Since the reox-
ygenation of (reversibly) sickled RBC(RSC) results in
the restoration of phospholipid asymmetry (1), we ex-
amined whether such a redistribution of membrane
components causes the dissociation of liposomes that
had adhered to (but not fused with) the sickled RBC
membrane. As shown in Fig. 7, -25% of liposome
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FIGURE 6 Effect of chelating agents on the incorporation
of liposomes into sickle RBC. Normal (circles) or sickle
(squares) RBCwere incubated with liposomes (100-400 uM)
as in Fig. 3 except that the incubation mixture contained 6
mMdisodium EDTA. The buffer used to wash the RBC-
liposome complex (following the incubation) also contained
6 mMdisodium EDTA. Oxygenated RBC (closed symbols)
were preincubated at 370C for 1 h in room air. Deoxygenated
RBC(open symbols) were preincubated at 370C for 1 h under
humidified nitrogen. Liposome composition, incorporation
into RBC, and measurement of cell number were described
in Fig. 1. Data points represent the mean±1 SD of three
determinations.
radioactivity bound to the deoxygenated sickle RBC
remained associated with the reoxygenated sickle
RBC, the remainder (-75%) being dissociated from
the membrane during reoxygenation. These results
suggest that liposome binding to sickled RBCinvolves
both a reversible and a nonreversible component. We
interpret the latter to be the result of nonreversible
RBC-liposome fusion and the former as representing
a reversible stable adhesion of liposomes to the RBC
surface.
Inhibition of sickling using liposomes containing
antisickling agents. In addition to using liposomes as
probes for investigating erythrocyte membrane sur-
face properties, a great deal of attention has focused,
of late, on the use of liposomes as vehicles to deliver
materials into cells (31). Since a large variety of agents
that inhibit the gelation of sickle Hb in vitro have now
been described (32, 33), but which are relatively im-
permeable to the RBCmembrane, it was of interest
to us to use liposomes as a transport system to deliver
antisickling agents into the sickle RBC. For this pur-
pose we prepared liposomes containing PHE, incu-
bated these liposomes with sickle RBCand then deox-
ygenated the cells after having washed away unbound








FIGURE 7 Effect of reoxygenation of deoxygenated sickle
RBCon liposome incorporation. Liposomes (200 ,uM) were
incubated at 37°C for 1 h with oxygenated (A) or deoxy-
genated (B) sickle RBC following which time an aliquot of
the deoxygenated cells were allowed to reoxygenate in room
air for an additional 15 min (C). Oxygenated and the re-
mainder of the deoxygenated RBCwere also incubated for
an additional 15 min so that all RBCwere incubated with
liposomes for a total of 75 min. Oxygenated RBCwere prein-
cubated at 37'C for 1 h in room air while deoxygenated
RBCwere preincubated at 37°C for 1 h under humidified
nitrogen. Liposome composition, incorporation into RBC,
and measurement of cell number were described in Fig. 1.
Values represent the mean±1 SD of three determinations.
TABLE II
Inhibition of Sickling Using PHE-loaded Liposomes
RBCtreatment' Incubation Percentage of sickle RBCI
min








' Oxygenated sickle RBCwere incubated with liposomes (1 mM)
containing 150 mMPHE (liposomes [PHE]) or with liposomes
+ PHE for 1 h at 37'C. The final concentration of PHE in the
incubation mixture was 0.3 mMfor both treatments. Following the
incubation, RBCwere washed twice with PBSto remove unreacted
liposomes and PHE, flushed with humidified nitrogen for 1 h at
37'C, and then fixed by the addition of deoxygenated 3% (final
concentration) glutaraldehyde.
t The results are presented as the percentage of RBC (mean of
duplicate determinations), which when examined under light mi-
croscopy possessed a "maple-leaf" morphology typical of RSC.
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to PHE-loaded liposomes were significantly more re-
sistant to sickling than were those RBCincubated with
empty liposomes plus free PHE. Furthermore, the in-
hibition of sickling was dose dependent with regards
to liposome-PHE concentration (data not shown). Not
only do these results strongly suggest that liposome-
RBC fusion had occurred, they also demonstrate a
potentially valuable clinical application of liposomes
in the therapy of sickle cell disease.
DISCUSSION
A large body of evidence has been gradually accu-
mulating which demonstrates that the plasma mem-
brane of the sickle RBCcontains components that con-
fer to this membrane unique surface properties. Al-
though some of these properties have thus far been
characterized only in the nonsickled (oxygenated)
sickle RBC, most are known to be accentuated by hy-
poxia-induced sickling. Recently, much attention has
focused on the clinical significance of these changes.
For example, Chiu et al. (34) have shown that sickled
RBCwere capable of enhancing blood coagulation in
vitro, presumably due to sickling-induced changes in
the phospholipid distribution of the outer membrane
leaflet that exposes PS. Hebbel et al. (10) and Hoover
et al. (9) have shown independently that sickle RBC
have a greater capacity for adhering to cultured en-
dothelial cells than do normal RBC, and suggested that
this increased adherence may be a pathologic factor
in the microvascular occlusions characteristic of sickle
cell disease. The purpose of the present report was to
extend the observations regarding altered surface
properties of the sickle RBCby using liposomes, which,
because of their relatively small size (0.1 um) should
l)e capable of extensive interactions with the RBC
membrane. Wefelt that using liposomes in such a way
might allow us to better characterize alterations in
sickle cell intermembrane interactions, especially those
that are accentuated by the sickling event and that
might not be so apparent in other assay systems. We
addressed the following questions: (a) are there dif-
ferences between normal and sickle RBC in the way
these cells interact with liposomes? if so, (b) what are
the mechanisms involved in liposome sickle RBC in-
teraction? and (c) can these differences be exploited
in a way to allow the use of liposomes as specific de-
livery systems for introducing potentially therapeutic
compounds into pathological cells?
We found that sickle RBC interacted to a greater
extent with liposomes than did normal cells and that
these differences were accentuated bv hypoxia-in-
duced sickling. In this regard, liposome binding to
sickle RBC could occur by one or a combination of
several possible mechanisms: (a) adhesion of the li-
posome to the RBCsurface, (b) endocytosis of the li-
posome by the RBC, (c) fusion of the liposome and
RBC membrane, and/or (d) phospholipid exchange
between liposomes and RBC. A priori, we excluded
endocytosis as a reasonable mechanism since mature
RBCare not known to be capable of spontaneous en-
docytosis under physiological conditions (35). Fur-
thermore, ghosts prepared from sickle RBC(which are
capable of drug-induced endocytosis) are less capable
of ATP-induced endocytosis than are normal RBC (36).
Wefound that liposome-RBC adhesion occurred for
both normal and sickle RBC. Hypoxic induction of
sickling (in RSC) stimulated additional liposome bind-
ing to these cells. Of this increment, -25% we inter-
preted as representing liposome fusion, since that pro-
portion of bound liposome was not reversible upon
reoxygenation. Furthermore, we found that liposome
binding to sickle cells could not be characterized as
secondary to stimulation by intracellular divalent cat-
ion leakage during sickling. Thus, we propose that the
sickling event results in some change(s) in the surface
of the sickled RBC that exposes additional liposome
binding sites, and that liposome binding occurs at least
partially through liposome-RBC fusion. Increases in
liposome binding to sickled RBC were apparent
whether we used liposomes tagged with an exchange-
able or a nonexchangeable lipid label, suggesting that
phospholipid exchange between liposomes and sickle
RBCwas not occurring to any significant extent.
Extrapolation of the data presented in Fig. 3 to zero
lipid added demonstrates significant base-line lipo-
some incorporation for both normal and sickle RBC.
From these results and those depicted in Fig. 2, which
suggests the existence of distinct populations of "high"-
and "low"-affinity liposome binding sites, we speculate
that observed differences in liposome binding to nor-
mal, oxygenated and deoxygenated sickle RBCreflects
differences in liposome binding to the "low"-affinity
liposome binding sites. At low liposome concentrations
(<100lM) the number of liposomes bound per RBC
is low (<100 liposomes/RBC) and perhaps insufficient
to saturate all of the "high"-affinity binding sites pres-
ent on and similar for both normal and sickle RBC.
At liposome concentrations >100 ,uM, where differ-
ences in liposome binding between normal, oxygen-
ated and deoxygenated sickle RBCwere observed, we
speculate that the "high"-affinity liposome binding
sites are saturated. Therefore, that we did not detect
differences in the extent of liposome binding between
sickled and nonsickled cells at liposome concentrations
.100 ,uM suggests that our assay system was insensitive
to differences in cell surface properties at this level.
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The nature of these additional liposome binding sites
was examined by treating normal RBCwith diamide,
which causes membrane alterations including a reor-
ganization of plasma membrane phospholipids result-
ing in the exposure on the outer leaflet of PS and ad-
ditional PE (22). Such changes in membrane redistri-
bution of PE and PS are similar to those found in
deoxygenated RSC (1). Wefound that liposome bind-
ing to diamide-treated RBC increased as the avail-
ability of PS and PE on the outer leaflet of the bilayer
increased. Thus, a strong correlation between the
availability of outer leaflet aminophospholipids and
liposome binding was established in these cells. It
should be noted that while the percentages of outer
leaflet PE and PS in diamide-treated RBCwere similar
to those previously reported for hypoxic sickle cells
(1), liposome binding was substantially lower than
would have been predicted for hypoxic sickle cells at
similar liposome concentrations. Thus, although a
qualitative relationship between phospholipid reor-
ganization and liposome binding was established, these
results also suggest that other, as yet unidentified com-
ponents in the hypoxic sickle cell membrane, are con-
tributing to enhanced liposome binding to these cells.
When liposome binding was examined in density-
separated RBC, we found that the extent of liposome
binding to normal RBC was greatest in the bottom
(most dense) fraction. In this regard, Schroit and col-
laborators2 have recently accumulated evidence which
suggests that normal RBC enriched in PS (by incu-
bation with PS liposomes) are phagocytized by cul-
tured mouse or human macrophages to a greater extent
than are nontreated, phosphatidic acid-enriched or
PC-enriched RBC. These workers speculate that phos-
pholipid redistribution in normal RBCmay occur nat-
urally as a consequence of cell aging and that exposure
of PS on the outer leaflet of the membrane may en-
hance the recognition and phagocytosis of these cells
by macrophages within the reticuloendothelial system.
Our results also suggest that as normal RBC mature
certain surface properties of these cells are altered in
such a way as to confer to these cells a potential for
increased intermembrane interactions.
In contrast to the results obtained for normal den-
sity-separated RBC, in sickle density-separated RBC
the extent of liposome binding was greatest in the top
(least dense) fraction. Since the bottom (most dense)
fraction was enriched in ISC compared to the top frac-
tion and ISC are known to contain elevated levels of
outer leaflet aminophospholipids (expressed as a per-
centage of total ISC membrane phospholipid) (1), it
2 Schroit, A. Personal communication.
should follow that liposome binding to ISC would be
enhanced if aminophospholipid redistribution were a
component of the mechanism underlying increased
liposome binding to hypoxic sickle RBC. That lipo-
some binding to ISC was not increased suggests that
aminophospholipid redistribution alone cannot explain
enhanced liposome binding to hypoxic sickle cells. It
should be mentioned that ISC are known to be different
from RSC in several respects, which may affect their
ability to interact extensively with liposomes. For ex-
ample, ISC are considerably smaller and contain less
total membrane lipid than do RSC (21). In addition,
ISC demonstrate abnormal rheological properties (37)
and contain irreversible cytoskeletal defects (7). Such
cumulative membrane defects may contribute to the
observed low levels of liposome binding to these cells.
That hypoxic Hb AS RBC bound fewer liposomes
than did hypoxic Hb SS RBCat similar liposome con-
centrations similarly suggests that liposome binding
can be affected by membrane components other than
the content of outer leaflet PE and PS, which is similar
for both cells (1). Wespeculate that in this case, dif-
ferences in liposome binding may be related to alter-
ations in the surface glycoprotein architecture of the
Hb SS RBCmembrane. In this regard, Fukuda et al.
(3), have demonstrated that Hb SS RBChave a higher
content of both i- and I-antigens. In addition, these
workers found that following treatment with endo-
B-galactosidase, Hb SS RBC released considerably
more sialic acid than did normal or nonsickle high
reticulocyte RBC. In related experiments, Hebbel et
al. (10) demonstrated by electron microscopy that Hb
SS RBC possess aberrations in surface charge distri-
bution presumably representing alterations in the sur-
face distribution of sialic acid. Thus, we speculate that
the mechanism underlying increased liposome binding
to Hb SS RBC involves both cooperative interactions
between permanent alterations in sickle RBC mem-
brane glycoprotein architecture and distribution of
surface charges, with transient alterations in the con-
tent and distribution of outer leaflet aminophospho-
lipids.
One possible application for the increased binding
of liposomes by sickled RBC may be in developing
new methods for the clinical treatment of sickle cell
disease. For example, liposomes containing antisick-
ling agents could be used to deliver intracellularly
agents that cannot penetrate the RBCmembrane. In-
deed, we have been able to partially inhibit sickling
in vitro using liposomes containing PHE. These results
not only strongly suggest that liposome-RBC fusion
had occurred, but point to the practical aspects of using
liposomes in the therapy of sickle cell disease. It is also
apparent from these studies that liposomes can be used
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as sensitive probes for investigating changes in the sur-
face properties of cell plasma membranes. Further-
more, by changing the lipid composition and size of
the liposome or by incorporating components such as
proteins or glycoproteins into the liposome membrane,
one can obtain further information regarding the in-
teraction of altered erythrocyte membranes with
model membranes of defined size and composition.
ACKNOWLEDGMENTS
The authors are grateful to Ms. Klara Kleman who per-
formed the stractan gradient cell separations and sickle cell
microscopy and to Mrs. Marion A. Douglass for her expert
assistance in the preparation of this manuscript.
This work was supported by March of Dimes grant 1-768
and National Institutes of Health grants HL-20985 and HL-
27059.
REFERENCES
1. Lubin, B., D. Chiu, J. Bastacky, B. Roelofsen, and L. L.
M. Van Deenen. 1981. Abnormalities in membrane phos-
pholipid organization in sickled erythrocytes. J. Clin.
Invest. 67: 1643-1649.
2. Franck, P., D. Chiu, B. Roelofsen, J. Op den Kamp, and
B. Lubin. 1982. Accelerated transbilayer movement of
phosphatidylcholine in sickled erythrocytes. Blood.
60(Suppl. 1): 45a. (Abstr.)
3. Fukuda, M., M. N. Fukuda, S. Hakomori, and T. Pa-
payannopoulou. 1981. Anomalous cell surface structure
of sickle cell anemia erythrocytes as demonstrated by
cell surface labeling and endo-IB-galactosidase treatment.
J. Supramol. Struct. Cell. Biochem. 17: 289-297.
4. Eaton, J. W., T. D. Skelton, H. S. Swofford, C. E. Kolpin,
and H. S. Jacob. 1973. Elevated erythrocyte calcium in
sickle cell disease. Nature (Lond.). 246: 105-106.
5. Palek, J. 1977. Red cell calcium content and transmem-
brane calcium movements in sickle cell anemia. J. Lab.
Clin. Med. 89: 1365-1374.
6. Asakura, T., K. Minakaza, K. Adachi, M. 0. Russel, and
E. Schwartz. 1977. Denatured hemoglobin in sickle
erythrocytes. J. Clin. Invest. 59: 633-640.
7. Lux, S. E., K-. M. John, and J. Karnovsky. 1976. Irre-
versible deformation of the spectrin-actin lattice in ir-
reversibly sickled cells. J. Clin. Invest. 58: 955-962.
8. Lubin, B., and D. Chiu. 1980. Abnormal susceptibility
of sickle erythrocytes to lipid peroxidation. In Red Blood
Cells and Lens Metabolism. S. Srivastava, editor. Elsev-
ier-North Holland, Inc., New York. 159-162.
9. Hoover, R., R. Rubin, G. Wise, and R. Warren. 1979.
Adhesion of normal and sickle erythrocytes to endothe-
lial monolayer cultures. Blood. 54: 872-876.
10. Hebbel, R. P., 0. Yamuda, C. F. Moldow, H. S. Jacob,
J. G. White, and J. W. Eaton. 1980. Abnormal adherence
of sickle erythrocytes to cultured vascular endothelium:
possible mechanism for microvascular occlusion in sickle
cell disease. J. Clin. Invest. 65: 154-160.
11. Hebbel, R. P., M. A. B. Boogaerts, J. W. Eaton, and
M. H. Steinberg. 1980. Erythrocyte adherence to endo-
thelium in sickle cell anemia: a possible determinant of
disease severity. N. Engl. J. Med. 302: 992-995.
12. Papahadjopoulos, D., W. J. Vail, C. Newton, S. Nir, K.
Jacobson, G. Poste, and R. Lazo. 1977. Studies on mem-
brane fusion. III. The role of calcium-induced phase
changes. Biochim. Biophys. Acta. 465: 579-598.
13. Papahadjopoulos, D., and N. Miller. 1967. Phospholipid
model membranes I. Structural characteristics of hy-
drated liquid crystals. Biochim. Biophys. Acta. 135: 624-
638.
14. Diizgiine*, N., J. Wilschut, R. Fraley, and D. Papahad-
jopoulos. 1981. Studies on the mechanism of membrane
fusion: role of head-group composition in calcium- and
magnesium-induced fusion of mixed phospholipid ves-
icles. Biochim. Biophys. Acta. 642: 182-195.
15. Szoka, F., and D. Papahadjopoulos. 1978. Procedure for
preparation of liposomes with large internal aqueous
space and high capture by reverse-phase evaporation.
Proc. Natl. Acad. Sci. USA. 75: 4194-4198.
16. Wilschut, J., N. Duzgune5, R. Fraley, and D. Papahad-
jopoulos. 1980. Studies on the mechanism of membrane
fusion: Kinetics of calcium ion-induced fusion of phos-
phatidylserine vesicles followed by a new assay for mix-
ing of aqueous vesicle contents. Biochemistry. 19: 6011-
6021.
17. Olson, F., C. A. Hunt, F. C. Szoka, W. J. Vail, and D.
Papahadjopoulos. 1979. Preparation of liposomes of de-
fined size distribution by extrusion through polycarbon-
ate membranes. Biochim. Biophys. Acta. 557: 9-23.
18. Szoka, F., F. Olson, T. Heath, W. Vail, E. Mayhew, and
D. Papahadjopoulos. 1980. Preparation of unilamellar
liposomes of intermediate size (0.1-0.2 jsm) by a com-
bination of reverse phase evaporation and extrusion
through polycarbonate membranes. Biochim. Biophys.
Acta. 601: 559-571.
19. Bartlett, G. R. 1959. Phosphorus assay in column chro-
matography. J. Biol. Chem. 234: 466-468.
20. Corash, L. M., S. Piomelli, H. C. Cohen, C. Seaman, and
E. Gross. 1974. Separation of erythrocytes according to
age on a simplified density gradient. J. Lab. Clin. Med.
84: 147-151.
21. Clark, M. R., R. C. Unger, and S. B. Shohet. 1978. Mono-
valent cation composition and ATP and lipid content of
irreversibly sickled cells. Blood. 51: 1169-1178.
22. Haest, C. W. M., G. Plasa, D. Kamp, and B. Deuticke.
1978. Spectrin as a stabilizer of the phospholipid asym-
metry in the human erythrocyte membrane. Biochim.
Biophys. Acta. 509: 21-32.
23. Bensinger, T. A., and P. N. Gillette. 1974. Hemolysis in
sickle cell disease. Arch. Intern. Med. 133: 624-631.
24. Chiu, D., B. Lubin, and S. Shohet. 1979. Erythrocyte
membrane lipid reorganization during the sickling pro-
cess. Br. J. Haematol. 41: 223-234.
25. Zilversmit, D. B., and M. E. Hughes. 1976. Phospholipid
exchange between membranes. Methods Membr. Biol.
7: 211-259.
26. Crain, R. C., and D. B. Zilversmit. 1980. Two nonspecific
phospholipid exchange proteins from beef liver. 2. Use
in studying the asymmetry and transbilayer movement
of phosphatidylcholine, phosphatidylethanolamine, and
sphingomyelin in intact rat erythrocytes. Biochemistry.
19: 1440-1447.
27. Enholm, C., and D. B. Zilversmit. 1973. Exchange of
various phospholipids and of cholesterol between lipo-
somes in the presence of highly purified exchange pro-
tein. J. Biol. Chem. 248: 1719-1724.
28. Struck, D., and R. Pagano. 1980. Insertion of fluorescent
Interaction of Liposomes with Sickle Erythrocytes 1579
phospholipids into the plasma membrane of a mam-
malian cell. J. Biol. Chem. 255: 5404-5410.
29. Dizgiine*, N., K. Hong, and D. Papahadjopoulos. 1980.
Membrane fusion: the involvement of phospholipids,
proteins and calcium binding. In Calcium Binding Pro-
teins: Structure and Function. F. L. Siegel, E. Carafoli,
R. H. Krestinger, D. H. MacLennan, and R. H. Wasser-
man, editors. Elsevier-North Holland, Inc., New York.
17-22.
30. Papahadjopoulos, D., G. Poste, and W. J. Vail. 1979.
Studies on membrane fusion with natural and model
membranes. Methods Membr. Biol. 10: 1-121.
31. Papahadjopoulos, D., editor. 1978. Liposomes and their
uses in biology and medicine. Ann. N.Y. Acad. Sci. 308:
226-425.
32. Dean, J. D., and A. N. Schechter. 1978. Sickle-cell ane-
mia: molecular and cellular bases of therapeutic ap-
proaches. N. Engl. J. Med. 299: 752-870.
33. Noguchi, C. T., and A. N. Schechter. 1978. Inhibition
of sickle hemoglobin gelation by amino acids and related
compounds. Biochemistry. 17: 5455-5459.
34. Chiu, D., B. Lubin, B. Roelofsen, and L. L. M. van Dee-
nen. 1981. Sickled erythrocytes accelerate clotting in
vitro: an effect of abnormal membrane lipid asymmetry.
Blood. 58: 398-401.
35. Schekman, R., and S. J. Singer. 1976. Clustering of mem-
brane receptors can be induced in mature erythrocytes
of neonatal but not adult humans. Proc. Natl. Acad. Sci.
USA. 73: 4075-4079.
36. Schrier, S. L., and K. G. Bensch. 1976. Endocytosis in
resealed human erythrocyte ghosts: abnormalities in
sickle cell anemia. In Membranes and Disease. L. Bolis,
J. F. Hoffman, and A. Leaf, editors. Raven Press, New
York. 31-40.
37. Chien, S., S. Usami, and J. F. Bertles. 1970. Abnormal
rheology of oxygenated blood in sickle cell anemia. J.
Clin. Invest. 49: 623-634.
1580 R. S. Schwartz, N. Diizguneq, D. T.-Y. Chiu, and B. Lubin
